ConductScience.org, home

Paper29367243

Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination.

Torrents de la Peña A and 9 others. J Virol, 2018. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination. Papers, record 29367243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination.
PubMed
Journal
J Virol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
2.5
iCite
Revised in PubMed
2025-05-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Torrents de la Peña AAlba
2de Taeye SWSteven W
3Sliepen KKwinten
4LaBranche CCCelia C
5Burger JAJudith A
6Schermer EEEdith E
7Montefiori DCDavid C
8Moore JPJohn P
9Klasse PJPer Johan
10Sanders RWRogier W

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
HIV-1Major topic
Immunogenicity, VaccineMajor topic
Protein MultimerizationMajor topic
env Gene Products, Human Immunodeficiency VirusMajor topic
Animals
Humans
Rabbits

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
280829European Research CouncilInternationalPubMedPubMed
P01 AI110657NIAID NIH HHSUnited StatesP01AI110657PubMed and NIHNIH RePORTER

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124068931A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.PLoS Pathog2013https://conductscience.org/library/papers/24068931PubMed
226457756Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.Nat Med2015https://conductscience.org/library/papers/26457756PubMed
325540368A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.J Virol2015https://conductscience.org/library/papers/25540368PubMed
428834745Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.Cell Rep2017https://conductscience.org/library/papers/28834745PubMed
523086475Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.Nat Med2012https://conductscience.org/library/papers/23086475PubMed
626372963Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26372963PubMed
728133806Native-like Env trimers as a platform for HIV-1 vaccine design.Immunol Rev2017https://conductscience.org/library/papers/28133806PubMed
826687358Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.Cell2015https://conductscience.org/library/papers/26687358PubMed
925662010Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies.Cell2015https://conductscience.org/library/papers/25662010PubMed
1015709015Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.J Virol2005https://conductscience.org/library/papers/15709015PubMed
1127627672Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.PLoS Pathog2016https://conductscience.org/library/papers/27627672PubMed
1227114034Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.Cell2016https://conductscience.org/library/papers/27114034PubMed
1326506369Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Viruses2015https://conductscience.org/library/papers/26506369PubMed
1420170767Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.Vaccine2010https://conductscience.org/library/papers/20170767PubMed
1526766578Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort.PLoS Pathog2016https://conductscience.org/library/papers/26766578PubMed
1629166592HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.Immunity2017https://conductscience.org/library/papers/29166592PubMed
1727545891Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies.Cell Rep2016https://conductscience.org/library/papers/27545891PubMed
1825589637A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.J Virol2015https://conductscience.org/library/papers/25589637PubMed
1916616287
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
Virology2006https://conductscience.org/library/papers/16616287PubMed
2026089353HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.Science2015https://conductscience.org/library/papers/26089353PubMed

See all 26 referencesDownload CSV of references

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42984752Immunogenicity and structure of a stabilized HIV-1 clade C Env from a pediatric elite neutralizer in complex with an autologous bnAb.Front Immunol2026https://conductscience.org/library/papers/42984752PubMed
42012184Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.J Virol2026https://conductscience.org/library/papers/42012184PubMed
41959402Decoding epitope immunodominance in HIV Env using cryoEM and machine learning.bioRxiv2026https://conductscience.org/library/papers/41959402PubMed
41884456Human immunodeficiency virus vaccines: Advances, challenges and future perspectives.World J Virol2026https://conductscience.org/library/papers/41884456PubMed
41238582Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles.NPJ Vaccines2025https://conductscience.org/library/papers/41238582PubMed
40835839Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques.NPJ Vaccines2025https://conductscience.org/library/papers/40835839PubMed
40511646Germline-Targeting Strategies to Induce bNAbs against HIV-1.Curr HIV Res2026https://conductscience.org/library/papers/40511646PubMed
40006695Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.Vaccines (Basel)2025https://conductscience.org/library/papers/40006695PubMed
40006657The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.Vaccines (Basel)2025https://conductscience.org/library/papers/40006657PubMed
39823319Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens.Sci Immunol2025https://conductscience.org/library/papers/39823319PubMed
39651156Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques.bioRxiv2025https://conductscience.org/library/papers/39651156PubMed
39508605Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.J Virol2024https://conductscience.org/library/papers/39508605PubMed
39361585Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.PLoS Pathog2024https://conductscience.org/library/papers/39361585PubMed
39248459Conformations of membrane human immunodeficiency virus (HIV-1) envelope glycoproteins solubilized in Amphipol A18 lipid-nanodiscs.J Virol2024https://conductscience.org/library/papers/39248459PubMed
38979012Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs.iScience2024https://conductscience.org/library/papers/38979012PubMed
38605096CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.Nat Commun2024https://conductscience.org/library/papers/38605096PubMed
38582771Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines.NPJ Vaccines2024https://conductscience.org/library/papers/38582771PubMed
38085509Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines.J Virol2024https://conductscience.org/library/papers/38085509PubMed
37696048Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.J Virol2023https://conductscience.org/library/papers/37696048PubMed
37640732Engaging an HIV vaccine target through the acquisition of low B cell affinity.Nat Commun2023https://conductscience.org/library/papers/37640732PubMed

See all 71 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29367243

GET https://conductscience.org/api/papers/v1/29367243/references?page=2